Triantafyllos Stylianopoulos

36PUBLICATIONS

72CO-AUTHORS

Molecular targetsTransport properties and non-equilibrium processesBiomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (36)

Sort by Publication Date:

|Jul 06, 2026

Rewiring tumour mechanosensing to overcome CAR T cell resistance.

|Jun 26, 2026

Hydrostatic pressure reduces the mechanosensitivity of cell migration.

|May 18, 2026

Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses.

|May 02, 2026

Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.

|Jan 30, 2026

Ensemble Machine Learning on Bulk RNA-Seq Identifies 17-Gene Signature Predicting Neoadjuvant Chemotherapy Response in Breast Cancer.

Stelios Lamprou, Styliana Georgiou, Triantafyllos Stylianopoulos

|Nov 28, 2025

Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.

John D Martin, Koji Nagaoka, Myrofora Panagi

Pageof 6

Frequent Collaborators

9 joint publications

Chrysovalantis Voutouri

8 joint publications

Fotios Mpkeris

7 joint publications

Andreas G Hadjigeorgiou

Myrofora Panagi

Rakesh K Jain

John D Martin

Christina Michael

Horacio Cabral

Constantinos Harkos

Lance L Munn

Frequent Collaborators

9 joint publications

Chrysovalantis Voutouri

8 joint publications

Fotios Mpkeris

7 joint publications

Andreas G Hadjigeorgiou

7 joint publications

Myrofora Panagi